Ignite Creation Date:
2025-12-25 @ 12:32 AM
Ignite Modification Date:
2025-12-25 @ 10:39 PM
Study NCT ID:
NCT04306367
Status:
COMPLETED
Last Update Posted:
2025-02-17
First Post:
2020-02-11
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of Pembrolizumab and Olaparib in Bile Duct Cancer
Sponsor:
Georgetown University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-04-01
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-12-19
Completion Date Type:
ACTUAL
First Submit Date:
2020-02-11
First Submit QC Date:
None
Study First Post Date:
2020-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-11-21
Results First Submit QC Date:
None
Results First Post Date:
2024-12-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-02-13
Last Update Post Date:
2025-02-17
Last Update Post Date Type:
ACTUAL